| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 4.68e-06 | 599 | 24 | 7 | GO:0050839 | |
| Domain | Ig_I-set | 1.18e-07 | 190 | 24 | 6 | IPR013098 | |
| Domain | I-set | 1.18e-07 | 190 | 24 | 6 | PF07679 | |
| Domain | IGc2 | 4.14e-07 | 235 | 24 | 6 | SM00408 | |
| Domain | Ig_sub2 | 4.14e-07 | 235 | 24 | 6 | IPR003598 | |
| Domain | TGFBI/POSTN | 1.58e-06 | 2 | 24 | 2 | IPR016666 | |
| Domain | - | 9.48e-06 | 4 | 24 | 2 | 2.30.180.10 | |
| Domain | FAS1 | 9.48e-06 | 4 | 24 | 2 | SM00554 | |
| Domain | FAS1 | 9.48e-06 | 4 | 24 | 2 | PS50213 | |
| Domain | Fasciclin | 9.48e-06 | 4 | 24 | 2 | PF02469 | |
| Domain | FAS1_domain | 9.48e-06 | 4 | 24 | 2 | IPR000782 | |
| Domain | IG | 1.21e-05 | 421 | 24 | 6 | SM00409 | |
| Domain | Ig_sub | 1.21e-05 | 421 | 24 | 6 | IPR003599 | |
| Domain | C2-set_2 | 1.92e-05 | 41 | 24 | 3 | PF08205 | |
| Domain | CD80_C2-set | 1.92e-05 | 41 | 24 | 3 | IPR013162 | |
| Domain | IG_LIKE | 2.88e-05 | 491 | 24 | 6 | PS50835 | |
| Domain | Ig-like_dom | 3.30e-05 | 503 | 24 | 6 | IPR007110 | |
| Domain | - | 1.52e-04 | 663 | 24 | 6 | 2.60.40.10 | |
| Domain | EMI_domain | 1.88e-04 | 16 | 24 | 2 | IPR011489 | |
| Domain | EMI | 2.13e-04 | 17 | 24 | 2 | PS51041 | |
| Domain | Ig-like_fold | 2.14e-04 | 706 | 24 | 6 | IPR013783 | |
| Domain | V-set | 1.63e-03 | 184 | 24 | 3 | PF07686 | |
| Domain | Ig_V-set | 2.04e-03 | 199 | 24 | 3 | IPR013106 | |
| Domain | - | 6.57e-03 | 95 | 24 | 2 | 2.60.120.200 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 8.31e-05 | 9 | 22 | 2 | MM14966 | |
| Pubmed | 1.02e-07 | 162 | 25 | 5 | 25826454 | ||
| Pubmed | TGFBI functions similar to periostin but is uniquely dispensable during cardiac injury. | 4.96e-07 | 2 | 25 | 2 | 28750100 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 18022324 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 24368280 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 30048528 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 26288337 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 29117645 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 23735324 | ||
| Pubmed | Comparative analysis of Neph gene expression in mouse and chicken development. | 1.49e-06 | 3 | 25 | 2 | 22205279 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 20233749 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 16874800 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 19478074 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 37357460 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 15907457 | ||
| Pubmed | Role of Neph2 in pontine nuclei formation in the developing hindbrain. | 7.43e-06 | 6 | 25 | 2 | 21241806 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 19110483 | ||
| Pubmed | A flexible, multilayered protein scaffold maintains the slit in between glomerular podocytes. | 1.04e-05 | 7 | 25 | 2 | 27430022 | |
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 18752272 | ||
| Pubmed | NEPH1 defines a novel family of podocin interacting proteins. | 1.39e-05 | 8 | 25 | 2 | 12424224 | |
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 37591863 | ||
| Pubmed | 3.26e-05 | 12 | 25 | 2 | 18296617 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 3.82e-05 | 91 | 25 | 3 | 28558017 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 23637329 | ||
| Pubmed | Alternative splice variants encoding unstable protein domains exist in the human brain. | 3.85e-05 | 13 | 25 | 2 | 15491607 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 7.54e-05 | 18 | 25 | 2 | 18834073 | |
| Pubmed | 1.60e-04 | 26 | 25 | 2 | 36178190 | ||
| Pubmed | 1.85e-04 | 28 | 25 | 2 | 38324473 | ||
| Pubmed | 2.28e-04 | 31 | 25 | 2 | 32046118 | ||
| Pubmed | 2.58e-04 | 33 | 25 | 2 | 24727668 | ||
| Cytoband | 12q12 | 3.03e-04 | 47 | 25 | 2 | 12q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q12 | 5.45e-04 | 63 | 25 | 2 | chr12q12 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.53e-07 | 161 | 19 | 5 | 593 | |
| GeneFamily | CD molecules|Mucins | 1.29e-06 | 21 | 19 | 3 | 648 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 7.97e-04 | 40 | 19 | 2 | 592 | |
| GeneFamily | Fibronectin type III domain containing | 1.21e-02 | 160 | 19 | 2 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 1.72e-02 | 193 | 19 | 2 | 594 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.94e-05 | 170 | 25 | 4 | M5880 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | 4.17e-05 | 703 | 25 | 6 | M39070 | |
| Coexpression | VERHAAK_AML_WITH_NPM1_MUTATED_DN | 8.73e-05 | 250 | 25 | 4 | M10117 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 1.18e-04 | 17 | 25 | 2 | M47995 | |
| Coexpression | DURAND_STROMA_S_UP | 1.76e-04 | 300 | 25 | 4 | M2581 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN | 1.81e-04 | 116 | 25 | 3 | M17778 | |
| Coexpression | DURAND_STROMA_S_UP | 1.85e-04 | 304 | 25 | 4 | MM1083 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_200 | 6.77e-06 | 33 | 24 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_200 | 6.77e-06 | 33 | 24 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_200 | 9.61e-06 | 37 | 24 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.11e-05 | 125 | 24 | 4 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 1.31e-05 | 41 | 24 | 3 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k2_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 1.41e-05 | 42 | 24 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 2.16e-05 | 148 | 24 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k3_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.24e-05 | 337 | 24 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.10e-05 | 354 | 24 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 8.00e-05 | 207 | 24 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 8.45e-05 | 76 | 24 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_100 | 1.49e-04 | 92 | 24 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 1.54e-04 | 93 | 24 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_100 | 1.85e-04 | 18 | 24 | 2 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.91e-04 | 100 | 24 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_100 | 2.07e-04 | 19 | 24 | 2 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 2.96e-04 | 116 | 24 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_100 | 3.05e-04 | 23 | 24 | 2 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 3.43e-04 | 122 | 24 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 3.60e-04 | 124 | 24 | 3 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.81e-04 | 311 | 24 | 4 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_200 | 4.55e-04 | 28 | 24 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k1_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.60e-04 | 327 | 24 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.65e-04 | 328 | 24 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200 | 4.82e-04 | 137 | 24 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_100 | 4.88e-04 | 29 | 24 | 2 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_100 | 5.22e-04 | 30 | 24 | 2 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_100 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#1_top-relative-expression-ranked_500 | 5.35e-04 | 142 | 24 | 3 | gudmap_developingKidney_e13.5_podocyte cells_500_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 5.46e-04 | 143 | 24 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 5.80e-04 | 146 | 24 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 6.03e-04 | 148 | 24 | 3 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200 | 6.52e-04 | 152 | 24 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_200 | 7.29e-04 | 158 | 24 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_200 | 7.70e-04 | 161 | 24 | 3 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_200 | 7.84e-04 | 162 | 24 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_200 | 9.97e-04 | 176 | 24 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_200 | 1.12e-03 | 183 | 24 | 3 | gudmap_dev gonad_e11.5_F_GonMes_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.15e-03 | 418 | 24 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 1.18e-03 | 421 | 24 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.20e-03 | 423 | 24 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | 1.30e-03 | 432 | 24 | 4 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500 | 1.34e-03 | 436 | 24 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_500 | |
| CoexpressionAtlas | Pluripotent Stem Cells-reprogram_NA_vs_Pluripotent Stem Cells-reprogram_OSK-l-N-p53KD-Confounder_removed-fold2.0_adjp0.05 | 1.39e-03 | 49 | 24 | 2 | PCBC_ratio_ESC_vs_iPSC_method-OSK-l-N-p53KD_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 1.46e-03 | 768 | 24 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.52e-03 | 204 | 24 | 3 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.72e-03 | 466 | 24 | 4 | GSM777050_500 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_200 | 1.75e-03 | 55 | 24 | 2 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k1_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_200 | 1.82e-03 | 56 | 24 | 2 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | 1.94e-03 | 819 | 24 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 2.03e-03 | 827 | 24 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 2.07e-03 | 831 | 24 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.11e-03 | 493 | 24 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.17e-03 | 231 | 24 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.20e-03 | 232 | 24 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | Myeloid Cells, MF.Medl.SLN, CD11b+ CD169+ F4/80+, Lymph Node, avg-2 | 2.36e-03 | 64 | 24 | 2 | GSM854322_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.42e-03 | 240 | 24 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.76e-08 | 198 | 25 | 5 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-06 | 176 | 25 | 4 | 29b71369503719c74888cd356ceb6724cfdcabd9 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.13e-06 | 183 | 25 | 4 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.20e-06 | 184 | 25 | 4 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.20e-06 | 184 | 25 | 4 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-06 | 185 | 25 | 4 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-06 | 185 | 25 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-06 | 186 | 25 | 4 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.49e-06 | 188 | 25 | 4 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 4.28e-06 | 198 | 25 | 4 | 827aa9d919bf6d670961e5501e17d351676127e3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 4.28e-06 | 198 | 25 | 4 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 4.28e-06 | 198 | 25 | 4 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | 4.28e-06 | 198 | 25 | 4 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.37e-06 | 199 | 25 | 4 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.37e-06 | 199 | 25 | 4 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.46e-06 | 200 | 25 | 4 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.46e-06 | 200 | 25 | 4 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.46e-06 | 200 | 25 | 4 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.50e-05 | 124 | 25 | 3 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 6.31e-05 | 139 | 25 | 3 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.61e-05 | 148 | 25 | 3 | c95a732163050cfb5d604c2a4c9eb1afa9f19a95 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.61e-05 | 148 | 25 | 3 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.39e-05 | 153 | 25 | 3 | 9c3220604b7fa4d91577b6c46960960f49644ca1 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.39e-05 | 153 | 25 | 3 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.39e-05 | 153 | 25 | 3 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.39e-05 | 153 | 25 | 3 | ba624782693b0daa642e50881dbf5f0663fea82d | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.39e-05 | 153 | 25 | 3 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epi_progenitor|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.72e-05 | 155 | 25 | 3 | be575a0096415705dba425002247289ff8f89474 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-microglial_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.41e-05 | 159 | 25 | 3 | 31ec8222c766cb614e1cf27f74ee9d99489eca5c | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 9.58e-05 | 160 | 25 | 3 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 9.76e-05 | 161 | 25 | 3 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | Control-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 9.94e-05 | 162 | 25 | 3 | e3b9b46ce2faff7d099502df14bbf51e9f183f8c | |
| ToppCell | Control-Epithelial-Ionocyte|Control / Disease state, Lineage and Cell class | 1.01e-04 | 163 | 25 | 3 | bf09fa39bf3e6b3a776d5e79c30c96df572956a3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.05e-04 | 165 | 25 | 3 | 8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.11e-04 | 168 | 25 | 3 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.13e-04 | 169 | 25 | 3 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 169 | 25 | 3 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 173 | 25 | 3 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 173 | 25 | 3 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-04 | 173 | 25 | 3 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 173 | 25 | 3 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.27e-04 | 176 | 25 | 3 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 177 | 25 | 3 | f28243b51be104cb3adcde63f03fc2206ed3121e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 179 | 25 | 3 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.34e-04 | 179 | 25 | 3 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.34e-04 | 179 | 25 | 3 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 179 | 25 | 3 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 179 | 25 | 3 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 179 | 25 | 3 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 180 | 25 | 3 | 7d3d5608647b6e684e8e185993d106a38c53e76a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 181 | 25 | 3 | 3dcb74b28f93be35ddf4de1937f7e30b25e11927 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-04 | 181 | 25 | 3 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 181 | 25 | 3 | 7679a5980011d6dfb1aaca7abf678c29b6f819bb | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 1.38e-04 | 181 | 25 | 3 | 94680f8dbdf22d83801abc0819417751d363fb12 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 182 | 25 | 3 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.40e-04 | 182 | 25 | 3 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 183 | 25 | 3 | c5caac6ed6c8d67f5c336281d9fd903976509445 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.43e-04 | 183 | 25 | 3 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-04 | 183 | 25 | 3 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-04 | 183 | 25 | 3 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 183 | 25 | 3 | 9d5a363fbe6f0a1668c9d584df65ee1c283349c7 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.43e-04 | 183 | 25 | 3 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 184 | 25 | 3 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-04 | 184 | 25 | 3 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-04 | 184 | 25 | 3 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-04 | 184 | 25 | 3 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.45e-04 | 184 | 25 | 3 | 8880ff36c243cc60a524d74934d000aef26a70ac | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-04 | 185 | 25 | 3 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 185 | 25 | 3 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 185 | 25 | 3 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.47e-04 | 185 | 25 | 3 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 185 | 25 | 3 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.47e-04 | 185 | 25 | 3 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | facs-BAT-Fat-24m-Epithelial-Epcam+|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 186 | 25 | 3 | b18d7398279a2d42414318aeb70514fd402f5a0a | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 1.50e-04 | 186 | 25 | 3 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 1.50e-04 | 186 | 25 | 3 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-04 | 186 | 25 | 3 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 187 | 25 | 3 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 187 | 25 | 3 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-04 | 187 | 25 | 3 | 2a7226adb4d15b92936603bdf05421c50b21f003 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-04 | 187 | 25 | 3 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.52e-04 | 187 | 25 | 3 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 187 | 25 | 3 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-04 | 187 | 25 | 3 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.52e-04 | 187 | 25 | 3 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 1.52e-04 | 187 | 25 | 3 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-04 | 188 | 25 | 3 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-04 | 188 | 25 | 3 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-04 | 189 | 25 | 3 | f01158bb15df3117fae1271bf8cf8c2501422671 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-04 | 189 | 25 | 3 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 189 | 25 | 3 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 1.57e-04 | 189 | 25 | 3 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-04 | 190 | 25 | 3 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | Monocytes-Tissue-resident_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.59e-04 | 190 | 25 | 3 | 07215e8f292cb54c670037aaf28393cddbe5548c | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 190 | 25 | 3 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.62e-04 | 191 | 25 | 3 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 191 | 25 | 3 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.62e-04 | 191 | 25 | 3 | 51535232e889db52a9b24e5696b1687e93dd7302 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.62e-04 | 191 | 25 | 3 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 1.62e-04 | 191 | 25 | 3 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| Disease | Sjogren's syndrome (is_marker_for) | 1.73e-04 | 24 | 24 | 2 | DOID:12894 (is_marker_for) | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 1.73e-04 | 24 | 24 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | hair morphology measurement | 8.84e-04 | 54 | 24 | 2 | EFO_0007821 | |
| Disease | Autism Spectrum Disorders | 2.17e-03 | 85 | 24 | 2 | C1510586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVVGSTTTQLYTDRT | 111 | Q15582 | |
| TVTEVTDYTTGRVGA | 476 | O60488 | |
| SGTGVALTDTYSRIT | 1731 | Q8IZF6 | |
| SPRVGTTRYTETSTV | 11 | A8MU93 | |
| VAGTETTSTTLRYGL | 296 | P10632 | |
| ITSTTDSVYTGGTEV | 2771 | P49792 | |
| TYTLTVETTSGPVTE | 146 | Q8WXI7 | |
| TTYSSGATTTGVVEV | 1626 | Q8IWI9 | |
| TTVTTAGSETTAVYT | 1286 | E2RYF6 | |
| AGSETTTVYITGSKT | 1351 | E2RYF6 | |
| GSTVYAESVILTTGT | 181 | Q9Y2Z2 | |
| IGTESTVETTTYIGE | 6491 | Q7Z5P9 | |
| TVETTTYIGESGTTR | 6496 | Q7Z5P9 | |
| RSTIEATTSFRGTGT | 7886 | Q7Z5P9 | |
| TLSESTAIISYGTTG | 121 | Q96G04 | |
| TISVDGILTTTGYTQ | 401 | Q9P2S2 | |
| TVGTENISTSTGEYT | 231 | P31644 | |
| EGSLSTVTIVYSGED | 786 | Q9UQ52 | |
| YTVERTNSGSGVLST | 441 | Q96J84 | |
| ESGTSGRYTVETIST | 461 | Q8IZU9 | |
| TSSVEGSIGSTSQYR | 1026 | Q5M9N0 | |
| ETTISGLTPETTYSV | 781 | P10586 | |
| TGVTTTSTVRLDVSY | 231 | Q9NYZ4 | |
| DGFTTTRSYGTVSQI | 36 | Q9NY25 | |
| STGVDYRGTVSVTKS | 316 | Q01973 | |
| STGGIYTVGVTTRTV | 181 | Q7Z4S6 | |
| YTVGVTTRTVNTESE | 186 | Q7Z4S6 | |
| KYTRISTGGGETEET | 761 | Q15063 | |
| VSISIISSTSGGSVY | 451 | Q3SY84 |